Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(4.01)
# 533
Out of 4,667 analysts
69
Total ratings
49.12%
Success rate
13.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOWL Werewolf Therapeutics | Reiterates: Buy | $15 | $1.63 | +821.72% | 15 | Nov 19, 2024 | |
| MURA Mural Oncology | Reiterates: Buy | $18 | $3.36 | +435.71% | 3 | Nov 14, 2024 | |
| ERAS Erasca | Reiterates: Buy | $6 | $2.71 | +121.40% | 8 | Nov 13, 2024 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $32.28 | +132.38% | 8 | Nov 13, 2024 | |
| SRRK Scholar Rock Holding | Maintains: Buy | $35 → $40 | $27.56 | +45.14% | 12 | Nov 12, 2024 | |
| IKNA Ikena Oncology | Reiterates: Buy | $4 | $1.69 | +136.69% | 11 | Nov 11, 2024 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $40 | $13.49 | +196.52% | 12 | Oct 31, 2024 |
Werewolf Therapeutics
Nov 19, 2024
Reiterates: Buy
Price Target: $15
Current: $1.63
Upside: +821.72%
Mural Oncology
Nov 14, 2024
Reiterates: Buy
Price Target: $18
Current: $3.36
Upside: +435.71%
Erasca
Nov 13, 2024
Reiterates: Buy
Price Target: $6
Current: $2.71
Upside: +121.40%
CG Oncology
Nov 13, 2024
Reiterates: Buy
Price Target: $75
Current: $32.28
Upside: +132.38%
Scholar Rock Holding
Nov 12, 2024
Maintains: Buy
Price Target: $35 → $40
Current: $27.56
Upside: +45.14%
Ikena Oncology
Nov 11, 2024
Reiterates: Buy
Price Target: $4
Current: $1.69
Upside: +136.69%
Day One Biopharmaceuticals
Oct 31, 2024
Reiterates: Buy
Price Target: $40
Current: $13.49
Upside: +196.52%